Compensation award — excluded from discretionary-purchase analysis.
Loading…
Planned for Sep 2, 2026 · Notice filed Sep 2, 2026
A board member of ResMed| told the SEC they plan to sell $228K of ResMed| shares around Sep 2, 2026. The shares came from their pay, which is the usual reason to sell.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
None found in footnotes
Only flagged when a footnote says so; never inferred
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
